U.S. stocks fluctuated today, with the major indices collectively experiencing a pullback. The Nasdaq fell over 2%, the S&P 500 fell by 1.56%, and the Dow Jones fell by 0.84%—Nvidia's earnings report exceeded expectations, which initially excited people, but investors soon began to worry about how long the AI market can sustain.
The individual stocks are making quite a stir:
PACS Group jumped directly by +56%, as the company's financial audit has finally been completed, with third-quarter revenue growing by 31% year-on-year to 1.34 billion, and net profit more than tripling. Investors are clearly waiting for this sigh of relief— the period of uncertainty is finally over.
Exact Sciences rose by 17%, acquired by Abbott Labs at a price of $105 per share, a premium of 22%. This transaction strengthens Abbott's cancer screening business and brings Exact Sciences shareholders back to their highest levels since 2021.
Bath & Body Works fell 25%, third-quarter sales declined, and fourth-quarter expectations are also not optimistic, with the full-year performance in 2025 potentially facing a cliff—double hit from tariffs and macro pressures.
SanDisk also fell by 20%. Although Bank of America raised the price target to $300, this stock soared from $50 in September to over $300, and investors are now starting to withdraw from AI-related speculation.
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
U.S. stocks fluctuated today, with the major indices collectively experiencing a pullback. The Nasdaq fell over 2%, the S&P 500 fell by 1.56%, and the Dow Jones fell by 0.84%—Nvidia's earnings report exceeded expectations, which initially excited people, but investors soon began to worry about how long the AI market can sustain.
The individual stocks are making quite a stir:
PACS Group jumped directly by +56%, as the company's financial audit has finally been completed, with third-quarter revenue growing by 31% year-on-year to 1.34 billion, and net profit more than tripling. Investors are clearly waiting for this sigh of relief— the period of uncertainty is finally over.
Exact Sciences rose by 17%, acquired by Abbott Labs at a price of $105 per share, a premium of 22%. This transaction strengthens Abbott's cancer screening business and brings Exact Sciences shareholders back to their highest levels since 2021.
Bath & Body Works fell 25%, third-quarter sales declined, and fourth-quarter expectations are also not optimistic, with the full-year performance in 2025 potentially facing a cliff—double hit from tariffs and macro pressures.
SanDisk also fell by 20%. Although Bank of America raised the price target to $300, this stock soared from $50 in September to over $300, and investors are now starting to withdraw from AI-related speculation.